Johnson & Johnson - stock earnings

JNJ Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
July 17, 2024 BeforeMarket - / - 21.9 billion - / 22.3 billion 22.6 billion

JNJ Quarterly earnings

DateEarningsRevenue
2024Q1 5.4 billion USD 21.4 billion USD
2023Q4 4.0 billion USD 21.4 billion USD
2023Q3 26.0 billion USD 21.3 billion USD
2023Q2 5.1 billion USD 25.5 billion USD
2023Q1 -68.0 million USD 24.7 billion USD
2022Q4 3.5 billion USD 23.7 billion USD
2022Q3 4.5 billion USD 23.8 billion USD
2022Q2 4.8 billion USD 24.0 billion USD
2022Q1 5.1 billion USD 23.4 billion USD
2021Q4 4.7 billion USD 24.8 billion USD
2021Q3 3.7 billion USD 23.3 billion USD
2021Q2 6.3 billion USD 23.3 billion USD
2021Q1 6.2 billion USD 22.3 billion USD
2020Q4 1.7 billion USD 22.5 billion USD
2020Q3 3.6 billion USD 21.1 billion USD
2020Q2 3.6 billion USD 18.3 billion USD
2020Q1 5.8 billion USD 20.7 billion USD
2019Q4 4.0 billion USD 20.7 billion USD
2019Q3 4.8 billion USD 20.7 billion USD
2019Q2 5.6 billion USD 20.6 billion USD
2019Q1 3.7 billion USD 20.0 billion USD
2018Q4 3.0 billion USD 20.4 billion USD
2018Q3 3.9 billion USD 20.3 billion USD
2018Q2 4.0 billion USD 20.8 billion USD
2018Q1 4.4 billion USD 20.0 billion USD
2017Q4 -10.7 billion USD 20.2 billion USD
2017Q3 3.8 billion USD 19.7 billion USD
2017Q2 3.8 billion USD 18.8 billion USD
2017Q1 4.4 billion USD 17.8 billion USD
2016Q4 3.8 billion USD 18.1 billion USD
2016Q3 4.3 billion USD 17.8 billion USD
2016Q2 4.0 billion USD 18.5 billion USD
2016Q1 4.3 billion USD 17.5 billion USD
2015Q4 3.2 billion USD 17.8 billion USD
2015Q3 3.4 billion USD 17.1 billion USD
2015Q2 4.5 billion USD 17.8 billion USD
2015Q1 4.3 billion USD 17.4 billion USD
2014Q4 2.5 billion USD 18.3 billion USD
2014Q3 4.7 billion USD 18.5 billion USD
2014Q2 4.3 billion USD 19.5 billion USD
2014Q1 4.7 billion USD 18.1 billion USD
2013Q4 3.5 billion USD 18.4 billion USD
2013Q3 3.0 billion USD 17.6 billion USD
2013Q2 3.8 billion USD 17.9 billion USD
2013Q1 3.5 billion USD 17.5 billion USD
2012Q4 2.6 billion USD 17.6 billion USD
2012Q3 3.0 billion USD 17.1 billion USD
2012Q2 1.4 billion USD 16.5 billion USD
2012Q1 3.9 billion USD 16.1 billion USD
2011Q4 218.0 million USD 16.3 billion USD
2011Q3 3.2 billion USD 16.0 billion USD
2011Q2 2.8 billion USD 16.6 billion USD
2011Q1 3.5 billion USD 16.2 billion USD
2010Q4 1.9 billion USD 15.6 billion USD
2010Q3 3.4 billion USD 15.0 billion USD
2010Q2 3.4 billion USD 15.3 billion USD
2010Q1 4.5 billion USD 15.6 billion USD
2009Q4 2.2 billion USD 16.6 billion USD
2009Q3 3.3 billion USD 15.1 billion USD
2009Q2 3.2 billion USD 15.2 billion USD
2009Q1 3.5 billion USD 15.0 billion USD
2008Q4 2.7 billion USD 15.2 billion USD
2008Q3 3.3 billion USD 15.9 billion USD
2008Q2 3.3 billion USD 16.5 billion USD
2008Q1 3.6 billion USD 16.2 billion USD
2007Q4 2.4 billion USD 16.0 billion USD
2007Q3 2.5 billion USD 15.0 billion USD
2007Q2 3.1 billion USD 15.1 billion USD
2007Q1 2.6 billion USD 15.0 billion USD
2006Q4 2.2 billion USD 13.7 billion USD
2006Q3 2.8 billion USD 13.3 billion USD
2006Q2 2.8 billion USD 13.4 billion USD
2006Q1 3.3 billion USD 13.0 billion USD
2005Q4 2.2 billion USD 12.6 billion USD
2005Q3 2.6 billion USD 12.3 billion USD
2005Q2 2.7 billion USD 12.8 billion USD
2005Q1 2.9 billion USD 12.8 billion USD
2004Q4 1.2 billion USD 12.8 billion USD
2004Q3 2.3 billion USD 11.6 billion USD
2004Q2 2.5 billion USD 11.5 billion USD
2004Q1 2.5 billion USD 11.6 billion USD
2003Q4 1.8 billion USD 11.3 billion USD
2003Q3 2.1 billion USD 10.5 billion USD
2003Q2 1.2 billion USD 10.3 billion USD
2003Q1 2.1 billion USD 9.8 billion USD
2002Q4 1.4 billion USD 9.4 billion USD
2002Q3 1.7 billion USD 9.1 billion USD
2002Q2 1.7 billion USD 9.1 billion USD
2002Q1 1.8 billion USD 8.7 billion USD
2001Q4 1.1 billion USD 8.4 billion USD
2001Q3 1.5 billion USD 8.2 billion USD
2001Q2 1.5 billion USD 8.3 billion USD
2001Q1 1.5 billion USD 7.8 billion USD
2000Q4 891.0 million USD 7.1 billion USD
2000Q3 1.3 billion USD 7.2 billion USD
2000Q2 1.3 billion USD 7.5 billion USD
2000Q1 1.3 billion USD 7.3 billion USD
1999Q4 785.0 million USD 7.2 billion USD
1999Q3 1.1 billion USD 6.7 billion USD
1999Q2 1.2 billion USD 6.9 billion USD
1999Q1 83.0 million USD 6.4 billion USD
1998Q4 49.0 million USD 6.9 billion USD
1998Q3 961.0 million USD 5.7 billion USD
1998Q2 1.0 billion USD 5.8 billion USD
1998Q1 1.0 billion USD 5.8 billion USD
1997Q4 630.0 million USD 5.6 billion USD
1997Q3 855.0 million USD 5.6 billion USD
1997Q2 909.0 million USD 5.7 billion USD
1997Q1 909.0 million USD 5.7 billion USD
1996Q4 556.0 million USD 5.5 billion USD
1996Q3 750.0 million USD 5.4 billion USD
1996Q2 791.0 million USD 5.4 billion USD
1996Q1 465.0 million USD 4.8 billion USD
1995Q4 465.0 million USD 4.8 billion USD
1995Q3 623.0 million USD 4.7 billion USD
1995Q2 661.0 million USD 4.8 billion USD
1995Q1 378.0 million USD 4.1 billion USD
1994Q4 378.0 million USD 4.1 billion USD
1994Q3 525.0 million USD 4.0 billion USD
1994Q2 495.0 million USD 3.5 billion USD
1994Q1 335.0 million USD 3.5 billion USD
1993Q4 335.0 million USD 3.5 billion USD
1993Q3 454.0 million USD 3.5 billion USD
1993Q2 495.0 million USD 3.5 billion USD
1993Q1 503.0 million USD 3.6 billion USD
1992Q4 -323.0 million USD 3.5 billion USD
1992Q3 425.0 million USD 3.5 billion USD
1992Q2 464.0 million USD 3.4 billion USD
1992Q1 464.0 million USD 3.4 billion USD
1991Q4 274.0 million USD 3.1 billion USD
1991Q3 363.0 million USD 3.1 billion USD
1991Q2 406.0 million USD 3.0 billion USD
1991Q1 418.0 million USD 3.1 billion USD
1990Q4 232.0 million USD 2.7 billion USD
1990Q3 314.0 million USD 2.9 billion USD
1990Q2 353.0 million USD 2.8 billion USD
1990Q1 244.0 million USD 2.8 billion USD
1989Q4 203.0 million USD 2.5 billion USD
1989Q3 265.0 million USD 2.5 billion USD
1989Q2 ? USD 2.4 billion USD
1989Q1 317.0 million USD 2.4 billion USD
1988Q4 ? USD 2.2 billion USD
1988Q3 ? USD 2.2 billion USD
1988Q2 ? USD 2.3 billion USD
1988Q1 ? USD 2.3 billion USD
1987Q4 ? USD 2.0 billion USD
1987Q3 ? USD 2.0 billion USD
1987Q2 ? USD 2.0 billion USD
1987Q1 ? USD 2.0 billion USD
1986Q4 ? USD 1.7 billion USD
1986Q3 ? USD 1.8 billion USD
1986Q2 ? USD 1.7 billion USD
1986Q1 ? USD 1.7 billion USD
1985Q4 ? USD 1.7 billion USD
1985Q3 ? USD 1.6 billion USD

JNJ Yearly earnings

DateEarningsRevenue
2023 35.2 billion USD 85.2 billion USD
2022 17.9 billion USD 94.9 billion USD
2021 20.9 billion USD 93.8 billion USD
2020 14.7 billion USD 82.6 billion USD
2019 15.1 billion USD 82.1 billion USD
2018 15.3 billion USD 81.6 billion USD
2017 1.3 billion USD 76.5 billion USD
2016 16.5 billion USD 71.9 billion USD
2015 15.4 billion USD 70.1 billion USD
2014 16.3 billion USD 74.3 billion USD
2013 13.8 billion USD 71.3 billion USD
2012 10.9 billion USD 67.2 billion USD
2011 9.7 billion USD 65.0 billion USD
2010 13.3 billion USD 61.6 billion USD
2009 12.3 billion USD 61.9 billion USD
2008 12.9 billion USD 63.7 billion USD
2007 10.6 billion USD 61.1 billion USD
2006 11.1 billion USD 53.3 billion USD
2005 10.4 billion USD 50.5 billion USD
2004 8.5 billion USD 47.3 billion USD
2003 7.2 billion USD 41.9 billion USD
2002 6.6 billion USD 36.3 billion USD
2001 5.7 billion USD 33.0 billion USD
2000 4.8 billion USD 29.1 billion USD
1999 4.2 billion USD 27.5 billion USD
1998 3.1 billion USD 23.7 billion USD
1997 3.3 billion USD 22.6 billion USD
1996 2.9 billion USD 21.6 billion USD
1995 2.4 billion USD 18.8 billion USD
1994 2.0 billion USD 15.7 billion USD
1993 1.8 billion USD 14.1 billion USD
1992 1.0 billion USD 13.8 billion USD
1991 1.5 billion USD 12.4 billion USD
1990 1.1 billion USD 11.2 billion USD
1989 1.1 billion USD 9.8 billion USD
1988 974.0 million USD 9.0 billion USD
1987 833.0 million USD 8.0 billion USD
1986 329.5 million USD 7.0 billion USD
1985 613.7 million USD 6.4 billion USD

JNJ

List: Champions

Price: $144.44

52 week price:
143.13
175.97

Dividend Yield: 0.03%

5-year range yield:
0.03%
3.35%

Forward Dividend Yield: 3.43%

Payout Ratio: 95.20%

Payout Ratio Range:
40.69%
589.80%

Dividend Per Share: 4.96 USD

Earnings Per Share: 6.73 USD

P/E Ratio: 30.40

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Volume: 6.9 million

Ebitda: 2.9 billion

Market Capitalization: 358.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 63

DGR3: 5.32%

DGR5: 5.43%

DGR10: 5.72%

DGR20: 7.64%

Links: